Healthy Returns: What drugmakers are saying about Trump’s looming pharmaceutical tariffs
What Johnson & Johnson and Eli Lilly are saying about Trump’s pharmaceutical tariffs, and Dexcom scores FDA approval for its glucose monitoring system.
